
News|Slideshows|March 10, 2017
Top 10 Primary Care Drugs Approved in Early 2017
Author(s)Leo Robert
Click through this slide summary for a look at some of the more significant approvals so far for primary care.
Advertisement
Just shy of 3 months into the new year, the FDA has already granted a number of new drug approvals and new indications for drugs already approved. Scroll through the slides above for a look at some of the more significant recent approvals for primary care.For a quick review of last year’s approvals, go to Top 20 Primary Care Drugs Approved in 2016. SOURCESCenterWatch: 2016 FDA Approved DrugsDrugs.com: New Drug ApprovalsÂ
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Investigational Dual GLP-1/GIP Agonist CT-388 Demonstrates 22.5% Placebo-Adjusted Weight Loss in Phase 2 Obesity Trial
2
The Obesity–Cardiometabolic Link: Root Causes, Screening, and Primary Care's Role
3
Centanafadine Granted FDA Priority Review for the Treatment of ADHD Across Pediatric and Adult Populations
4
GRAIL Submits FDA Premarket Approval Application for Galleri Multi-Cancer Early Detection Blood Test
5































































































































